Seno gets $2m in state funding:
This article was originally published in Clinica
Executive Summary
Opto-acoustic technology specialist Seno Medical Instruments has been awarded $2m from the Texas Emerging Technology Fund (TETF), a $200m government investment programme aimed at financing local advancing technology projects. This investment allows San Antonio, Texas-based Seno to further develop its breast cancer imaging technology, and work towards implementing initial clinical trials on technology at the Cancer Therapy and Research Center, and the University of Texas Health Science Center. The company is aiming to provide a device that uses optics and acoustics, instead of x-ray radiation, to capture an accurate image of a tumour.